Literature DB >> 19752032

Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms.

Qian Liu1, Krishnan Sundar, Pankaj K Mishra, Gity Mousavi, Zhugong Liu, Andrew Gaydo, Farhang Alem, David Lagunoff, David Bleich, William C Gause.   

Abstract

Parasitic helminth infection has been shown to modulate pathological inflammatory responses in allergy and autoimmune disease. The aim of this study was to examine the effects of infection with a helminth parasite, Heligmosomoides polygyrus, on type 1 diabetes (T1D) in nonobese diabetic (NOD) mice and to elucidate the mechanisms involved in this protection. H. polygyrus inoculation at 5 weeks of age protected NOD mice from T1D until 40 weeks of age and also inhibited the more aggressive cyclophosphamide-induced T1D. Moreover, H. polygyrus inoculation as late as 12 weeks of age reduced the onset of T1D in NOD mice. Following H. polygyrus inoculation of NOD mice, pancreatic insulitis was markedly inhibited. Interleukin-4 (IL-4), IL-10, and IL-13 expression and the frequency of CD4(+) CD25(+) FoxP3(+) regulatory T cells were elevated in mesenteric and pancreatic lymph nodes. Depletion of CD4(+) CD25(+) T cells in vivo did not abrogate H. polygyrus-induced T1D protection, nor did anti-IL-10 receptor blocking antibody. These findings suggest that infection with H. polygyrus significantly inhibits T1D in NOD mice through CD25- and IL-10-independent mechanisms and also reduces the severity of T1D when administered late after the onset of insulitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752032      PMCID: PMC2786463          DOI: 10.1128/IAI.01170-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts.

Authors:  E Song; N Ouyang; M Hörbelt; B Antus; M Wang; M S Exton
Journal:  Cell Immunol       Date:  2000-08-25       Impact factor: 4.868

2.  Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group.

Authors:  M Karvonen; M Viik-Kajander; E Moltchanova; I Libman; R LaPorte; J Tuomilehto
Journal:  Diabetes Care       Date:  2000-10       Impact factor: 19.112

3.  Epidemiology of type I diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade.

Authors:  E J Schoenle; M Lang-Muritano; S Gschwend; J Laimbacher; P E Mullis; T Torresani; A Biason-Lauber; L Molinari
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

4.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.

Authors:  K Goudy; S Song; C Wasserfall; Y C Zhang; M Kapturczak; A Muir; M Powers; M Scott-Jorgensen; M Campbell-Thompson; J M Crawford; T M Ellis; T R Flotte; M A Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes.

Authors:  Divya J Mekala; Rajshekhar S Alli; Terrence L Geiger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

6.  Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.

Authors:  D G Alleva; R P Pavlovich; C Grant; S B Kaser; D I Beller
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

7.  Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

Authors:  S M Kamal; J W Rasenack; L Bianchi; A Al Tawil; K El Sayed Khalifa; T Peter; H Mansour; W Ezzat; M Koziel
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

8.  Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice.

Authors:  D Elias; H Akuffo; C Thors; A Pawlowski; S Britton
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

9.  Type 1 diabetes mellitus in Czech children diagnosed in 1990-1997: a significant increase in incidence and male predominance in the age group 0-4 years. Collaborators of the Czech Childhood Diabetes Registry.

Authors:  O Cinek; V Lánská; S Kolousková; Z Sumník; M Snajderová; K S Rønningen; J Vavrinec
Journal:  Diabet Med       Date:  2000-01       Impact factor: 4.359

Review 10.  Protective immune mechanisms in helminth infection.

Authors:  Robert M Anthony; Laura I Rutitzky; Joseph F Urban; Miguel J Stadecker; William C Gause
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

View more
  54 in total

1.  Metabolic Consequences of Concomitant Strongyloides stercoralis Infection in Patients With Type 2 Diabetes Mellitus.

Authors:  Anuradha Rajamanickam; Saravanan Munisankar; Yukthi Bhootra; Chandrakumar Dolla; Kannan Thiruvengadam; Thomas B Nutman; Subash Babu
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

Review 2.  Concise Review: Macrophages: Versatile Gatekeepers During Pancreatic β-Cell Development, Injury, and Regeneration.

Authors:  Naomi Van Gassen; Willem Staels; Eva Van Overmeire; Sofie De Groef; Mozhdeh Sojoodi; Yves Heremans; Gunter Leuckx; Mark Van de Casteele; Jo A Van Ginderachter; Harry Heimberg; Nico De Leu
Journal:  Stem Cells Transl Med       Date:  2015-04-06       Impact factor: 6.940

3.  Globule Leukocytes and Other Mast Cells in the Mouse Intestine.

Authors:  Peter Vogel; Laura Janke; David M Gravano; Meifen Lu; Deepali V Sawant; Dorothy Bush; E Shuyu; Dario A A Vignali; Asha Pillai; Jerold E Rehg
Journal:  Vet Pathol       Date:  2017-05-11       Impact factor: 2.221

Review 4.  Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance.

Authors:  Meng Wang; Linxiang Wu; Rennan Weng; Weihong Zheng; Zhongdao Wu; Zhiyue Lv
Journal:  Parasitol Res       Date:  2017-06-29       Impact factor: 2.289

Review 5.  Helminth infection and type 1 diabetes.

Authors:  Paola Zaccone; Samuel W Hall
Journal:  Rev Diabet Stud       Date:  2012-12-28

6.  STAT6 and IL-10 are required for the anti-arthritic effects of Schistosoma mansoni via different mechanisms.

Authors:  Y Osada; Y Horie; S Nakae; K Sudo; T Kanazawa
Journal:  Clin Exp Immunol       Date:  2018-10-15       Impact factor: 4.330

Review 7.  Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.

Authors:  Vivekanandhan Aravindhan; Gowrishankar Anand
Journal:  Am J Trop Med Hyg       Date:  2017-10-26       Impact factor: 2.345

Review 8.  Tuftsin phosphorylcholine-a novel compound harnessing helminths to fight autoimmunity.

Authors:  Yahel Segal; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 9.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 10.  Parasitic helminths: new weapons against immunological disorders.

Authors:  Yoshio Osada; Tamotsu Kanazawa
Journal:  J Biomed Biotechnol       Date:  2010-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.